Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

24.97
-1.1500-4.40%
Post-market: 24.970.00000.00%16:56 EDT
Volume:729.85K
Turnover:18.44M
Market Cap:2.84B
PE:-10.05
High:26.08
Open:25.69
Low:24.91
Close:26.12
52wk High:30.06
52wk Low:8.93
Shares:113.58M
Float Shares:108.11M
Volume Ratio:0.96
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:5.40
PE(LYR):-10.27

Loading ...

Immunome says Phase 3 RINGSIDE trial shows varegacestat cuts desmoid tumor progression or death risk 84%

Reuters
·
May 30

Immunome Is Maintained at Buy by Truist Securities

Dow Jones
·
May 29

Immunome price target raised to $37 from $36 at Truist

TIPRANKS
·
May 28

Immunome Initiated at Overweight by Barclays

Dow Jones
·
May 28

Barclays Initiates Immunome at Overweight With $36 Price Target

MT Newswires Live
·
May 28

Immunome (IMNM) Receives a New Rating from Barclays

TIPRANKS
·
May 28

Immunome management presents at Goldman Sachs Global Healthcare Conference

Reuters
·
May 27

Immunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial

TIPRANKS
·
May 23

Stock Track | Immunome Inc. Soars 6.28% in Pre-market on Insider Buying

Stock Track
·
May 19

Immunome director Jean Jacques Bienaime buys 5,000 shares for $103,500

Reuters
·
May 19

LifeSci Capital Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
May 16

Immunome Is Maintained at Outperform by Leerink Partners

Dow Jones
·
May 16

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Aveanna Healthcare Holdings (AVAH) and QT Imaging Holdings (QTI)

TIPRANKS
·
May 14

Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
May 13

Immunome (IMNM) Gets a Buy from Guggenheim

TIPRANKS
·
May 13

Immunome Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 13

Immunome reports Q1 EPS (48c), consensus (54c)

TIPRANKS
·
May 13

Analysts Are Bullish on Top Healthcare Stocks: Immunome (IMNM), Kalaris Therapeutics (KLRS)

TIPRANKS
·
May 13

Immunome Q1 EPS $(0.48) Beats $(0.57) Estimate

Benzinga Earnings
·
May 13

Immunome Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13